Irsogladin
| |
| Nazivi | |
|---|---|
| IUPAC naziv
6-(2,5-Dihlorofenil)-1,3,5-triazin-2,4-diamin
| |
| Drugi nazivi
DCPDAT
| |
| Identifikacija | |
| ChemSpider | |
| Svojstva | |
| C9H7Cl2N5 | |
| Molarna masa | 256,09 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
| Reference infokutije | |
Irsogladin je inhibitor fosfodiesteraze.[3]
Reference
[уреди | уреди извор]- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Satoh, H; Amagase, K; Takeuchi, K (2013). „Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats”. The Journal of Pharmacology and Experimental Therapeutics. 348 (2): 227—35. PMID 24254524. doi:10.1124/jpet.113.208991.